logo







Home>Companies>Abbisko-therapeutics-hkg-02256


Abbisko therapeutics (hkg: 02256)

Abbisko therapeutics (hkg: 02256)



Abbisko Therapeutics (HKG: 02256) is a biopharmaceutical company focused on the discovery and development of innovative small molecule therapies for oncology.
Sign up today to get real-time market insights on Abbisko therapeutics (hkg: 02256) and hundreds of other pre-IPO companies



Abbisko therapeutics (hkg: 02256) Overview

2016
Biotech
https://www.abbisko.com



Abbisko therapeutics (hkg: 02256) Live Market Data

$00000000
$00000000




Abbisko therapeutics (hkg: 02256) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO10/13/2021
Series D1/8/2021
Series C2/11/2020
Series B1/7/2019
Series A22/14/2017
Series A1
7/1/2016




Abbisko therapeutics (hkg: 02256) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
Qiming Venture PartnersSeries D, Series B, Series A2, Series CSeries D (2021-01-08)
GIC (Singapore)Series B, Series CSeries B (2019-01-07)
Loyal Valley CapitalSeries B, Series CSeries B (2019-01-07)
Temasek HoldingsSeries D, Series CSeries D (2021-01-08)
Greater Bay Area HomelandSeries DSeries D (2021-01-08)
The Carlyle Group (NAS: CG)Series DSeries D (2021-01-08)




Abbisko therapeutics (hkg: 02256) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Abbisko therapeutics (hkg: 02256) data




Abbisko therapeutics (hkg: 02256) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Abbisko therapeutics (hkg: 02256) data








Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.